Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2003. The increased amount of exits for fund were in 2013. This Tactics II Investments works on 38 percentage points more the average amount of lead investments comparing to the other organizations.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Tactics II Investments, startups are often financed by Tactics II Stem Cell Ventures, Wisconsin Alumni Research Foundation, Venture Investors. The meaningful sponsors for the fund in investment in the same round are Wisconsin Alumni Research Foundation, Venture Investors, State of Wisconsin Investment Board. In the next rounds fund is usually obtained by Venture Investors, Baird Capital, Wisconsin Alumni Research Foundation.
The fund has no exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Genetics, Biotechnology. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Roche NimbleGen, Cellular Dynamics International.
Related Funds
| Fund Name | Location |
| Bravio Capital | - |
| Breakpoint Ventures | Chicago, Illinois, United States |
| Dr. Max Iann Invest | - |
| Firstrock Capital | New York, New York, United States |
| Huitong Yongxin Touzi | Beijing, Beijing, China |
| Ignition Group | Italy, Lombardia, Milano |
| Koonras Technologies | Israel, Tel Aviv, Tel Aviv District |
| Medra Capital | England, London, United Kingdom |
| Nippon Life Insurance Company of Japan | Japan, Osaka, Osaka Prefecture |
| Numbrs | Switzerland, Zürich, Zurich |
| Rockport Venture Partners | New Jersey, Spring Lake, United States |
| Sabby Management | New Jersey, Saddle River, United States |
| Savano Capital Partners | Baltimore, Maryland, United States |
| Shenzhen Linhong Ruifeng Touzi Guanli Youxian Zeren Gongsi | China, Guangdong, Tianjin |
| SIGMAXYZ | Japan, Tokyo |
| Volcano Capital | New York, New York, United States |
| Wasserstein Adelson Ventures | New York, New York, United States |
| Yuliang Electronic Commerce | China, Yiwu, Zhejiang |
| Zhencheng Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellular Dynamics International | $21M | 06 Nov 2012 | Madison, Wisconsin, United States | ||
Roche NimbleGen | $10M | 17 Oct 2001 | Madison, Wisconsin, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellular Dynamics International | $21M | 06 Nov 2012 | Madison, Wisconsin, United States | ||
Roche NimbleGen | $10M | 17 Oct 2001 | Madison, Wisconsin, United States |
